Nishant C. Saxena

CIK: 0002136365

Transaction Breakdown

Open Market Buys (P)3 (75.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

CRBP
Corbus Pharmaceuticals Holdings, Inc.
Aug 11, 2026
Purchase(P)
Direct
2.6K shares at avg. $9.63$25K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jun 3, 2026
Purchase(P)
Direct
9K shares at avg. $7.58$68K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jun 2, 2026
Purchase(P)
Direct
4.5K shares at avg. $7.33$33K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
May 21, 2026
Award(A)
Direct
58.3K shares-

		Type	Shares	Price		Ownership
Aug 11, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Purchase(P)	2,600	$9.63	$25,036	Direct
Jun 3, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Purchase(P)	9,000	$7.58	$68,220	Direct
Jun 2, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Purchase(P)	4,500	$7.33	$32,999	Direct
May 21, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	58,300	-	$0	Direct

1-4 of 4 transactions

About Saxena Nishant C

Saxena Nishant C (SEC CIK 0002136365) files insider reports with the SEC as Chief Business Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP).

Signal8 holds 4 ownership filings by Saxena Nishant C (1 Form 3, 3 Form 4), filed between May 22, 2026 and Aug 12, 2026. Those filings report 4 transactions, from May 21, 2026 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Saxena Nishant C's filings is in NORWOOD, MA.

Recent filings by Saxena Nishant C

Aug 11, 2026: Open-market purchase of CRBP shares (Form 4, code P).
Jun 3, 2026: Open-market purchase of CRBP shares (Form 4, code P).
Jun 2, 2026: Open-market purchase of CRBP shares (Form 4, code P).
May 21, 2026: Grant or award of CRBP shares (Form 4, code A).

Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Cormorant Asset Management, LP, Officer
Ben Yong, Director
Nicacio Leonardo Viana, Chief Medical Officer
Cohen Yuval, Chief Executive Officer
Moran Sean F., Chief Financial Officer
Kung Winston, Director

How to read Form 4 transaction codes